Protection against influenza virus infection by a two-dose regimen of nasal vaccination using vaccines combined with cholera toxin B subunit
- 1 August 1989
- Vol. 7 (4), 314-320
- https://doi.org/10.1016/0264-410x(89)90192-8
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Enhancement of protective antibody responses by cholera toxin B subunit inoculated intranasally with influenza vaccineVaccine, 1989
- Protection against influenza virus infection by vaccine inoculated intranasally with cholera toxin B subunitVaccine, 1988
- FIELD TRIAL OF ORAL CHOLERA VACCINES IN BANGLADESHThe Lancet, 1986
- A lavage technique allowing repeated measurement of IgA antibody in mouse intestinal secretionsJournal of Immunological Methods, 1984
- Cross‐protection in mice infected with influenza A virus by the respiratory route is correlated with local IgA antibody rather than serum antibody or cytotoxic T cell reactivityEuropean Journal of Immunology, 1984
- Cross‐protection and cross‐reactive cytotoxic T cells induced by influenza virus vaccines in miceEuropean Journal of Immunology, 1980
- ASSESSMENT OF INACTIVATED INFLUENZA-A VACCINE AFTER THREE OUTBREAKS OF INFLUENZA A AT CHRIST'S HOSPITALThe Lancet, 1979
- Formation of Secretory and Circulating Antibodies after Immunization with Live and Inactivated Influenza Virus VaccinesThe Journal of Infectious Diseases, 1977
- INFLUENZA AT CHRIST'S HOSPITAL: MARCH, 1974The Lancet, 1976
- Gangliosides as membrane receptors for tetanus toxin, cholera toxin and serotoninNature, 1974